Marketing Research

Vantage Point: Payers—the "experts" in healthcare research

Vantage Point: Payers—the "experts" in healthcare research

Access to payers is about knowledge, about understanding what they do in their jobs

Forest and Deloitte to collaborate

By

ConvergeHEALTH by Deloitte has entered into a multi-year collaboration with Forest Labs and Intermountain Healthcare to conduct outcomes research.

WorldOne re-organizes, unifies around Sermo

WorldOne re-organizes, unifies around Sermo

By

The pharma market research major is working on unifying into one company with two main product lines, and is also in the process of a re-brand.

Vantage Point: Determining "fair market value"

Vantage Point: Determining "fair market value"

Should pharma formulate a super matrix to determine the FMV of research incentives?

Symphony finds Rx hike from Medicaid claims

Symphony finds Rx hike from Medicaid claims

By

The Affordable Care Act has spurred double-digit increases in demand for pharmaceuticals, new data suggest.

IMS Health raises $1.3B in NY IPO

IMS Health raises $1.3B in NY IPO

By

IMS Health raised $1.3 billion last month in its New York IPO.

Vantage Point: Marketing Support for Clinical Trials

Vantage Point: Marketing Support for Clinical Trials

Pharmaceutical companies must provide robust marketing support for their clinical trials

Checklist to gauge real-world studies

By

Researchers have developed and tested a checklist that aims to evaluate comparative effectiveness research and distinguish real-world studies that are good enough for decision-making about treatments.

Merck diversifies its Big Data agenda

Merck diversifies its Big Data agenda

By

Merck has broadened its analytics approach to include team-ups with a slate of organizations at the intersection of Big Data and health IT.

Vantage Point: Boosting Quality, Containing Costs

Vantage Point: Boosting Quality, Containing Costs

A new industry has emerged to provide analytics and predictive tools that support optimized care

LIlly comes on board at think tank

LIlly comes on board at think tank

By

National Pharmaceutical Council (NPC) said Eli Lilly joined earlier this year

Market research vies for more of pharma's ear

Market research vies for more of pharma's ear

By

Suppliers are touting a deeper level of analysis, in some cases bypassing the market-research function and reaching the highest levels of their pharma clients.

Vantage Point: Observational Research

Vantage Point: Observational Research

Pharma can be in the moment with customers as they interact with our information or products

IMS to go public, says acquisitions possible

IMS to go public, says acquisitions possible

By

The data and analytics giant is looking to launch an IPO. The company, which is the subject of an antitrust suit, said in its prospectus that it anticipates future acquisitions.

FDA seeks EMR data-mining partner

The regulator's proposed database could help identify adverse events.

Vantage Point: Big Data

Vantage Point: Big Data

Big Data is coming and with it the danger of pharmaceutical marketers relying on it too heavily

IMS Health acquires HGS Europe

By

IMS Health brought market access firm HGS Europe into the fold last month.

Vantage Point: Ringing in the new market

Vantage Point: Ringing in the new market

In 2014, the "new healthcare marketing" will become more discontinuous from the old

Patients use research tool to vote on Lemtrada

Patients use research tool to vote on Lemtrada

By

When an FDA advisory panel met last month to vote on whether to recommend approval of Sanofi's MS drug Lemtrada, patient opinion leaders had already voiced their view.

CMS rolls out new researcher tool

By

The Centers for Medicare and Medicaid Services (CMS) unveiled a new research tool last month.

Vantage Point: Putting secondary research first

Vantage Point: Putting secondary research first

As I pull out my crystal ball, I see a day where we WANT to use secondary research first

Vantage Point: The Next Generation of Drugs

Vantage Point: The Next Generation of Drugs

The next generation of drugs sees a number of market access challenges

Lilly-Humana data pact to focus on outcomes

Lilly-Humana data pact to focus on outcomes

By

Eli Lilly is tapping Humana's claims database for therapeutic study

ACC collaborates on CV database

By

The American College of Cardiology (ACC) said it's entered an agreement to cull insights from a healthcare database

Research tool taps patient KOLs via mobile

Research tool taps patient KOLs via mobile

By

The first on-demand way to tap the influencer community in healthcare went live today, and results of a real-world test show it has the potential to accelerate the research process.

GSK and nonprofit shrink Big Data down to size

GSK and nonprofit shrink Big Data down to size

By

The partnership seeks to improve medication adherence through predictive analytics.

Vantage Point: A Revolution in Research

Vantage Point: A Revolution in Research

A quiet revolution is underway in research to keep pace with changes in medical marketing

Symphony's suit alleges IMS Health "monopoly"

Symphony's suit alleges IMS Health "monopoly"

By

Symphony Health Solutions filed an antitrust lawsuit against IMS Health, accusing it of trying to monopolize the pharma data and analytics market

NIH to invest $96M in Big Data

By

The NIH said it will fund up to $24 million per year for four years to establish six to eight Big Data to Knowledge (BD2K) Centers of Excellence

Vantage Point: The End of Illness

Vantage Point: The End of Illness

The best-selling book "The End of Illness" illustrates an exciting new way to think of healthcare—and healthcare marketing research

UBC's access unit sold to private equity firm

UBC's access unit sold to private equity firm

By

Private equity firm Symphony Technology Group acquired several divisions of United BioSource Corp.

Wearable camera logs a user's day

Wearable camera logs a user's day

By

Memoto's tiny clip-on camera provides a detailed timeline of a patient's daily activities

Vantage Point: The value of market research

Vantage Point: The value of market research

For the client-side market researcher, "doing more with less" is a mantra, if not a corporate way of life

Study finds link between innovation and revenue

Study finds link between innovation and revenue

By

A study, offers for the first time, according to researchers, empirical evidence of the link between a company's culture from a commercial-operations standpoint and revenue performance.

Consultants see big growth in India

By

Double-digit growth and a fragmented healthcare system in India have spurred consultancies and data firms, although experts say pricing for services varies widely.

Vantage Point: Qualitative Marketing Research

Vantage Point: Qualitative Marketing Research

For all the advances in technology and methodology, qualitative research cannot shed its history like its quant sibling

M3 lands ex-Epocrates research head, others

M3 lands ex-Epocrates research head, others

By

Athenahealth has wasted little time in putting its mark on Epocrates

The reasons behind Big Data's rise

By

Fiscal concerns are paramount in the rise of Big Data within healthcare, according to a recent McKinsey analysis, but clinical trends also play a role

Vantage Point: Another look at marketing data

Vantage Point: Another look at marketing data

"External drivers" can have a significant impact on determining the answer to your marketing question

IMS Health acquires SaaS firm Appature

IMS Health acquires SaaS firm Appature

By

Healthcare data and analytics giant IMS Health bought Seattle-based software-as-a-service (SaaS) company Appature.

NYU launches degree in data science

By

New York University is forming a Center for Data Science, plus a master's-level degree program to prepare the next generation of data professionals

Vantage Point: Using real-world data

Vantage Point: Using real-world data

Marketing teams are not going to succeed in the future without a real understanding of the real world

CMS carve-out clears clouds over research

CMS carve-out clears clouds over research

By

"The marketing research community should be very satisfied with the additional guidance on the Sunshine Act from CMS," said the PMRG's government affairs committee chair

GSK Consumer joins retail think tank

By

GSK Consumer Health Care is the newest member of a research organization that conducts experiments into how shoppers think and behave.

Vantage Point: Should suppliers be partners?

Vantage Point: Should suppliers be partners?

A foundational premise of agency-of-record and preferred-provider relationships has a fatal flaw

Pfizer, Humedica ink real-world data pact

Pfizer, Humedica ink real-world data pact

By

Pfizer and clinical data outfit Humedica jointly announced their intent to collaborate on studies examining the effectiveness of treatments.

New CEO heads Symphony's quartet

By

Frank Lavelle officially became CEO of data and analytics provider Symphony Health Solutions in mid-January.

Vantage Point: Hepatitis C

Vantage Point: Hepatitis C

As it became evident that a large HCV+ cohort would likely need medical intervention, pharma responded

Social network deepens real-world data offering

Social network deepens real-world data offering

By

PatientsLikeMe, the online patient network and research platform, appointed Daphne Psacharopoulos to the new position of VP, client services and strategic initiatives

Email Newsletters